Stem
cells therapy are emerging as an important therapeutic option in the
field of cartilage regeneration. Rapid development of stem cell-based
therapy for cartilage regeneration in the recent past has been
witnessed across the world. Stem cells are mainly classified in three
kinds of cells: hematopoietic stem cell, mesenchymal stem cells, and
pluripotent stem cells.
The
global stem cell cartilage regeneration market size was valued at US$
254.4 million in 2017, and is expected to witness a CAGR of 8.9% over
the forecast period (2018 – 2026).
Request
Free Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2448
Increasing
Adoption of Minimally Invasive Surgery Procedures is expected to
Drive Growth of Stem Cell Cartilage Regeneration Market
Stem cell therapy for knees, minimally invasive procedure, has the
potential to decrease inflammation, halt progression of arthritic
damage, repair joint cartilage, and delay or avoid knee replacement
surgery. Injection of progenitor cells, especially mesenchymal stem
cells (MSCs), has been found to be an effective and better solution
for repairing degenerative cartilage compared to implantation of
differentiated cells such as articular cartilage.
In addition to this, other potential benefits such as lower risk and
shorter duration of minimally invasive surgery procedures are
expected to fuel demand for stem cell therapy for cartilage
regeneration during the forecast period. For instance, according to
NCBI 2016 report, a minimally invasive procedure to harvest stem
cells from both fat and bone marrow and inject the concentrated cells
under image guidance can be performed in 2-3 hours.
Stem
Cell Cartilage Regeneration Market - Regional Insights
On the basis of region, the global stem cell cartilage regeneration
market is segmented into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa. North America is expected to be the
most conducive region for growth of the stem cell cartilage
regeneration market over the forecast period, due to high presence of
key players in the region. Key players such as Vericel Corporation,
Osiris Therapeutics, among others are focusing on various growth
strategies such as gaining regulatory product approvals and launching
innovative stem cell based cartilage regeneration products and
technologies in the market.
Stem
Cell Cartilage Regeneration Market - Competitive Landscape
Key players operating in the global stem cell cartilage regeneration
market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd.,
Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc.,
BioTissue SA, and Vericel Corporation.
Detailed
Segmentation:
Global
Stem Cell Cartilage Regeneration Market, By Stem Cell Type:
-
Hematopoietic Stem Cells (HSCs)
-
Pluripotent Stem Cells (iPSC/ESCs)
-
Mesenchymal Stem Cells (MSCs)
Global
Stem Cell Cartilage Regeneration Market, By Treatment:
-
Microfracture
-
Osteochondral Transplant
-
Autologous Chondrocyte Implantation
-
Stem Cell Injections
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
